TrialBMJ open2016

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.

Alicia Calderone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.